CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Analyst Reco. Charles River Laboratories International, Inc. Xetra

Equities

RV6

US1598641074

Delayed Xetra Other stock markets 09:05:34 10/08/2022 pm IST			5-day change	1st Jan Change
215.8 ^EUR	-2.40%		-.--%	-.--%

13/06	Baird Adjusts Price Target on Charles River Laboratories International to $271 From $270	MT
07/06	The job report just threw a spanner in the works

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Baird Adjusts Price Target on Charles River Laboratories International to $271 From $270	13/06	MT
Mizuho Initiates Charles River Laboratories International With Neutral Rating, $235 Price Target	07/06	MT
ANALYST RECOMMENDATIONS : Lyft, Amazon, Fedex, Xpo, Unilever...	07/06
ANALYST RECOMMENDATIONS : American Airlines, Salesforce, Five Below, Tesla, Okta...	06/06
TD Cowen Adjusts Price Target on Charles River Laboratories International to $228 From $260	13/05	MT
JPMorgan Adjusts Price Target on Charles River Laboratories International to $270 From $280	10/05	MT
Jefferies Adjusts Price Target on Charles River Laboratories International to $226 From $235	10/05	MT
Evercore ISI Adjusts Price Target on Charles River Laboratories International to $265 From $300	10/05	MT
Baird Adjusts Price Target on Charles River Laboratories International to $270 From $282	10/05	MT
Zacks Investment Research Adjusts Charles River Laboratories International's Price Target to $259 From $278	12/04	MT
Charles River Laboratories Signs Plasmid DNA Manufacturing Deal With Ship of Theseus	04/04	MT
Deutsche Bank Raises Price Target on Charles River Laboratories to $300 From $275, Keeps Buy Rating	22/03	MT
Argus Raises Price Target on Charles River Laboratories International to $290 From $200, Maintains Buy Rating	18/03	MT
Deutsche Bank Raises Charles River Laboratories International Price Target to $275 From $245, Maintains Buy Rating	16/02	MT
Morgan Stanley Raises Price Target on Charles River Laboratories International to $235 From $205, Keeps Equalweight Rating	16/02	MT
TD Cowen Adjusts Charles River Laboratories International's PT to $260 From $193, Keeps Market Perform Rating	15/02	MT
Stephens Adjusts Charles River Laboratories International's PT to $280 From $270, Keeps Overweight Rating	15/02	MT
Citigroup Adjusts Price Target on Charles River Laboratories International to $250 From $215, Maintains Neutral Rating	15/02	MT
UBS Adjusts Charles River Laboratories International Price Target to $290 From $270, Maintains Buy Rating	15/02	MT
JPMorgan Adjusts Price Target on Charles River Laboratories International to $280 From $270, Maintains Overweight Rating	15/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Charles River Laboratories International, Inc. Xetra

Equities

RV6

US1598641074

Analyst Reco.

Filters